STOCK TITAN

Lifestance Health Group (LFST) Stock News

LFST Nasdaq

Welcome to our dedicated page for Lifestance Health Group news (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on Lifestance Health Group stock.

LifeStance Health Group reports developments as a Nasdaq-listed provider of virtual and in-person outpatient mental healthcare. The company serves children, adolescents and adults through psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy.

Recurring news themes include quarterly operating results, visit volumes, clinician productivity, center-level margin trends, cash flow, debt and capital allocation. Company updates also cover secondary common stock offerings by selling stockholders, share repurchase activity, investor conference presentations, executive and board changes, and corporate-status announcements tied to its outpatient mental health services business.

Rhea-AI Summary

LifeStance Health Group announced a secondary public offering of 20 million shares of common stock by certain stockholders. The underwriters are given a 30-day option to purchase an additional 3 million shares. LifeStance will not sell any shares or receive any proceeds from this offering. The offering is made under a shelf registration statement filed with the SEC on May 21, 2024. Morgan Stanley, Goldman Sachs & TPG Capital are the underwriters. The prospectus is available on the SEC's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.33%
Tags
-
Rhea-AI Summary

LifeStance Health Group, Inc. (Nasdaq: LFST) reported strong financial results for Q1 2024, with a revenue increase of 19% to $300.4 million, driven by higher visit volumes and improved revenue per visit. The clinician base also grew by 15%, reaching 6,866 clinicians. The company posted a net loss of $21.1 million, attributed to stock-based compensation, and an Adjusted EBITDA of $27.7 million. LifeStance reiterated its full-year revenue guidance of $1.19 billion to $1.24 billion, raising Center Margin expectations to $353 to $373 million, and Adjusted EBITDA to $88 to $98 million. The company also expects to maintain positive Free Cash Flow for the year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.96%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.65%
Tags
conferences earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.13%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.9%
Tags
conferences earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
conferences

FAQ

What is the current stock price of Lifestance Health Group (LFST)?

The current stock price of Lifestance Health Group (LFST) is $8.98 as of June 19, 2026.

What is the market cap of Lifestance Health Group (LFST)?

The market cap of Lifestance Health Group (LFST) is approximately 3.4B.